Ohcanbohtosat - Busaidy, Naifa

The Year in Medical Thyroidology Review: Current Challenges and Future Directions Dahkki Busaidy, Naifa Lamki

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease Dahkki Busaidy, Naifa Lamki, Cabanillas, Maria E.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Unilateral renal artery stenosis with renal atrophy in a patient with metastatic papillary thyroid carcinoma treated with sorafenib Dahkki Shawa, Hassan, Busaidy, Naifa L, Schellingerhout, Dawid, Habra, Mouhammed Amir

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Challenges Associated with Tyrosine Kinase Inhibitor Therapy for Metastatic Thyroid Cancer Dahkki Cabanillas, Maria E., Hu, Mimi I., Durand, Jean-Bernard, Busaidy, Naifa L.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion–Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metast... Dahkki Waguespack, Steven G., Tewari, Sanjit O., Busaidy, Naifa L., Zafereo, Mark E.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Safe and Effective Dosing of Basal–Bolus Insulin in Patients Receiving High-Dose Steroids for Hyper-Cyclophosphamide, Doxorubicin, Vincristine, and Dexamethasone Chemotherapy Dahkki Brady, Veronica, Thosani, Sonali, Zhou, Shouhou, Bassett, Roland, Busaidy, Naifa Lamki, Lavis, Victor

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Extreme hypothyroidism associated with sunitinib treatment for metastatic renal cancer Dahkki Fabbro, Egidio Del, Dev, Rony, Cabanillas, Maria E., Busaidy, Naifa L., Rodriguez, EdenMae C., Bruera, Eduardo

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

OR27-6 Combination Vemurafenib (BRAF Inhibitor)/Cobimetinib (MEK Inhibitor)/Atezolizumab (Anti-PDL1 Inhibitor) in BRAF-V600E Mutated Anaplastic Thyroid Cancer (ATC): Initial Safety... Dahkki Cabanillas, Maria, Busaidy, Naifa, Dadu, Ramona, Ferrarotto, Renata, Gross, Neil, Gule-Monroe, Maria, Lu, Charles, Grosu, Horiana, Williams, Michelle, Zafereo, Mark

Viečča ollesdeavstta Viečča ollesdeavstta

Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway Dahkki Busaidy, Naifa L., Farooki, Azeez, Dowlati, Afshin, Perentesis, John P., Dancey, Janet E., Doyle, Laurence A., Brell, Joanna M., Siu, Lillian L.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer–Related Diarrhea and Its Effects on Quality of Life: A Pilot Study Dahkki Dadu, Ramona, Hu, Mimi I., Cleeland, Charles, Busaidy, Naifa L., Habra, Mouhammed, Waguespack, Steven G., Sherman, Steven I., Ying, Anita, Fox, Patricia, Cabanillas, Maria E.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Phase I Clinical Trials in 56 Patients with Thyroid Cancer: The M. D. Anderson Cancer Center Experience Dahkki Tsimberidou, Apostolia Maria, Vaklavas, Christos, Wen, Sijin, Hong, David, Wheler, Jennifer, Ng, Chaan, Naing, Aung, Tse, Susan, Busaidy, Naifa, Markman, Maurie, Sherman, Steven I., Kurzrock, Razelle

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Cushing's syndrome secondary to ectopic ACTH secretion: The University of Texas MD Anderson Cancer Center Experience Dahkki Ejaz, Shamim, Vassilopoulou-Sellin, Rena, Busaidy, Naifa L., Hu, Mimi I., Waguespack, Steven G., Jimenez, Camilo, Ying, Anita K., Cabanillas, Maria, Abbara, Maher, Habra, Mouhammed Amir

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

MON-LB015 Sporadic MTC in Children: Characterization of a Rare Disease Dahkki Gammons, Sarah, Hu, Mimi I, Zafereo, Mark E, Busaidy, Naifa L, Perrier, Nancy D, Bassett, Roland L, Hyde, Samuel M, Grubbs, Elizabeth G, Waguespack, Steven G

Viečča ollesdeavstta Viečča ollesdeavstta

Acquired Secondary RAS Mutation in BRAF(V600E)-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors Dahkki Cabanillas, Maria E., Dadu, Ramona, Iyer, Pryianka, Wanland, Kacey B., Busaidy, Naifa L., Ying, Anita, Gule-Monroe, Maria, Wang, Jennifer R., Zafereo, Mark, Hofmann, Marie-Claude

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer Dahkki Tam, Samantha, Amit, Moran, Boonsripitayanon, Mongkol, Cabanillas, Maria E., Busaidy, Naifa L., Gunn, G. Brandon, Lai, Stephen Y., Gross, Neil D., Sturgis, Erich M., Zafereo, Mark E.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer Dahkki Amit, Moran, Tam, Samantha, Boonsripitayanon, Mongkol, Cabanillas, Maria E., Busaidy, Naifa L., Grubbs, Elizabeth Gardner, Lai, Stephen Y., Gross, Neil D., Sturgis, Erich M., Zafereo, Mark E.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Immune-Related Thyroiditis with Immune Checkpoint Inhibitors Dahkki Iyer, Priyanka C., Cabanillas, Maria E., Waguespack, Steven G., Hu, Mimi I., Thosani, Sonali, Lavis, Victor R., Busaidy, Naifa L., Subudhi, Sumit K., Diab, Adi, Dadu, Ramona

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine Dahkki Jaber, Tania, Waguespack, Steven G, Cabanillas, Maria E, Elbanan, Mohamed, Vu, Thinh, Dadu, Ramona, Sherman, Steven I, Amit, Moran, Santos, Elmer B, Zafereo, Mark, Busaidy, Naifa L

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

MON-LB097 The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier Dahkki Waguespack, Steven, Busaidy, Naifa, Hu, Mimi, Grubbs, Elizabeth, Weitzman, Steven, Wirth, Lori, Zafereo, Mark, Babiarz, Joshua, Hao, Yangyang, Huang, Jing, Kennedy, Giulia, Walsh, P. Sean, Kloos, Richard

Viečča ollesdeavstta Viečča ollesdeavstta

Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer Dahkki Dadu, Ramona, Waguespack, Steven G., Sherman, Steven I., Hu, Mimi I., Busaidy, Naifa L., Jimenez, Camilo, Habra, Mohammed A., Ying, Anita K., Bassett, Roland L., Cabanillas, Maria E.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta